Background COVID-19, SARS and MERS are diseases that present an important health
burden worldwide. This situation demands resource allocation to the healthcare system, …

BACKGROUND: The numbers of cases of arboviral diseases have increased in tropical and
subtropical regions while the coronavirus disease (COVID-19) pandemic overwhelms …

Objective: To identify and assess the current evidence available about the costs of managing
hospitalized pediatric patients diagnosed with Respiratory Syncytial Virus (RSV) and …

CONTEXT AND OBJECTIVE: The current health crisis due to COVID-19 is forcing us to
profoundly rethink our social organizations and practices in health. While there is no effective …

Objective To synthesize the available data on the economic burden of Coronavirus Diseases
2019 (COVID-19), Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory …

SciELO - Brasil - COVID-19 and patients with immune-mediated inflammatory diseases
undergoing pharmacological treatments: a rapid living systematic review COVID-19 and patients …

Introdução: Anualmente, são registrados mais de 30 milhões de casos da doença pelo Vírus
Sincicial Respiratório (VSR) em todo mundo, com aproximadamente 200 mil mortes. Cerca …

CONTEXT AND OBJECTIVE Coronavirus disease 2019 (COVID-19) has emerged in China
in December 2019 and rapidly spread. Although extraordinary efforts have been made on …

CONTEXT AND OBJECTIVE We propose to systematically review the available evidence to
evaluate if patients with immune mediated inflammatory diseases under pharmacological …

Context and objective: While cases of COVID-19 disease increase daily worldwide, outbreaks
of arboviral infections have affected health systems of countries in tropical regions. The …